ASEI price reflects the fact that their earnings have been inconsistent and there has not been any real evidence of growth with the ASEI. A spike in earnings for one quarter will propels short term stock gains, but long term it won't be enough.
The potential revenue from the CAARS deal is not priced into the stock price in my opinion, but that may be an indication that the street doesnt think it will ever materialize. There are risks that CAARS will never get funded (or will get defunded) or that another competitor will get the bulk of the revenue from CAARS.
All this ranting about the stock being worth $100 is only valid if ASEI executes. To date, they have not shown the ability to execute and get big deals consistently.
Sure they announce a deal here and there, but this is big time fellows. This isnt the circus tent you are playing in.